LATEST NEWS

June 12, 2025

A CURE FOR TYPE 1 DIABETES; ARE WE THERE YET?

The review article "A Cure for Type 1 Diabetes: Are We There Yet?" by Christopher Schaaf and Lori Sussel, provides a comprehensive overview of advancements in Type 1 Diabetes (T1D) treatment and the ongoing quest for a cure.

January 30, 2024

DIAGNODE 3 STUDY: DIABETES VACCINE DIAMYD® (GAD65-ALUM) IN PEOPLE WITH HLA DR3-DQ2 HAPLOTYPE

Earlier we reported publication of the first results of the Diagnode-1 and Diagnode-2 studies, testing Diamyd Medical's diabetes vaccine GAD-alum (Diamyd®) in people with recently diagnosed type 1 diabetes. Diamyd Medical is now recruiting people for the Diagnode 3 study.

June 20, 2023

UPDATE PUBLICATIONS

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter authors were involved:

April 12, 2023

UPDATE PSYCHOLOGY PUBLICATIONS 2022-2023

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter psychologist Giesje Nefs was involved:

March 7, 2023

SECOND PUBLICATION OF JDRF-PROJECT ‘BIOMARKERS OF HETEROGENEITY IN TYPE 1 DIABETES’

C-peptide and long-standing T1D

July 4, 2022

UPDATE PUBLICATIONS FIRST HALF OF 2022

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter, or employees of Diabeter, were involved

January 25, 2022

UPDATE PUBLICATIONS 2021/2022

We have updated the Diabeter Research website with a number of publications of studies in which Diabeter, or employees of Diabeter, were involved

November 17, 2021

CONSENSUS STATEMENT DO-IT-YOURSELF AUTOMATED INSULIN DELIVERY SYSTEMS

Recently a consensus statement on the use of open-source insulin delivery (AID) systems was published. Diabeter pediatrician Per Winterdijk, himself an open-source AID system user, contributed to the statement

November 10, 2021

LIFE EXPECTANCY, MORTALITY, PREVENTION OF COMPLICATIONS AND HOPE

Disturbing statistics on diabetes were presented in the Dutch press in October 2021

October 4, 2021

FIRST PUBLICATION OF JDRF-PROJECT ‘BIOMARKERS OF HETEROGENEITY IN TYPE 1 DIABETES’

C-peptide and impaired awareness of glycemia

June 1, 2021

PROGRESS TOWARDS PREVENTION OF TYPE 1 DIABETES: TEPLIZUMAB

Approval of Teplizumab for further application and development

February 15, 2021

“NEW CLOSED-LOOP INSULIN SYSTEMS”: REVIEW OF RECENT CLOSED-LOOP SYSTEMS

February 2, 2021